Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MaxLinear, Inc. (Nasdaq: MXL) SEC filings, offering a structured view of the company’s regulatory disclosures as a U.S. public issuer. MaxLinear operates in the semiconductor and related device manufacturing industry, supplying RF, analog, digital and mixed-signal integrated circuits for connectivity, infrastructure, and industrial and multi-market applications.
Through its filings with the U.S. Securities and Exchange Commission, MaxLinear reports financial results, material events, and risk factors. Current reports on Form 8‑K have disclosed unaudited quarterly financial results, including net revenue, margins, operating expenses, and earnings measures, as well as the authorization of a share repurchase program that allows the company to buy back a specified amount of its common stock over a multi-year period. These 8‑K filings often incorporate related press releases by reference.
Investors can use this filings page to locate MaxLinear’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain detailed discussions of the company’s business, segment information, risk factors, management’s discussion and analysis, and notes to the financial statements. The risk factor sections elaborate on topics highlighted in press releases, such as competition in the semiconductor industry, market cyclicality, trade and tariff issues, geopolitical conditions, customer demand variability, legal proceedings, and technology and cybersecurity considerations.
In addition to periodic reports, users can review Forms 8‑K for announcements about financial results, share repurchase authorizations, and other significant events. Where applicable, insider transaction reports on Form 4 and proxy statements on Schedule 14A can provide further insight into executive and director share ownership, equity awards, and governance matters. Stock Titan’s interface is designed to surface these filings as they are made available through EDGAR and to pair them with AI-powered summaries that explain key points, highlight important changes, and help readers interpret complex sections of lengthy documents such as 10‑K and 10‑Q reports.
MaxLinear, Inc. filed a current report to let investors know it has released its unaudited financial results for the fourth quarter and full year ended December 31, 2025. The company issued a press release on January 29, 2026, which is attached as an exhibit.
The press release is furnished as Exhibit 99.1 and provides the detailed quarterly and annual financial information, while the report itself clarifies that this information is not deemed filed for liability purposes under certain securities laws.
MaxLinear, Inc. reported that its board of directors has approved a share repurchase program authorizing the buyback of up to $75 million of its common stock through November 20, 2028. Repurchases may be made in the open market, through block trades, or via privately negotiated transactions, including under Rule 10b5-1 trading plans, in compliance with Rule 10b-18. The program is discretionary, does not require the company to repurchase any shares, and can be modified, suspended, or terminated at any time based on factors such as liquidity, share price, market conditions, and legal requirements.
MaxLinear, Inc. (MXL) reported insider transactions by a director. On 10/29/2025, the director sold 9,055 shares of common stock at $15.8693. On 10/30/2025, the director sold 20,747 shares at a $15.3928 weighted-average price, with underlying trades between $15.39 and $15.415. Following these sales, the director held 12,141 shares directly.
MaxLinear, Inc. (MXL) reported Q3 2025 results showing higher sales and narrower losses. Net revenue reached $126.5 million versus $81.1 million a year ago, lifting gross profit to $71.9 million. Operating expenses were $113.2 million, including $11.3 million in restructuring charges, resulting in a loss from operations of $41.3 million. Net loss improved to $45.5 million (basic and diluted EPS $(0.52)) from $75.8 million (EPS $(0.90)$) in Q3 2024.
For the nine months, revenue was $331.2 million with a net loss of $121.8 million. Cash, cash equivalents and restricted cash totaled $113.3 million at quarter‑end, alongside $125.0 million of term debt maturing in 2028 (weighted average effective rate ~7.0%). Operating cash flow turned positive at $9.2 million year‑to‑date, aided by working capital movements. Stockholders’ equity was $464.7 million. As of October 15, 2025, MaxLinear had 87,372,834 common shares outstanding.
MaxLinear, Inc. filed an 8-K to report that it issued a press release announcing its unaudited financial results for the third quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 and incorporated by reference.
The company states the information is being furnished under Item 2.02 and shall not be deemed filed for purposes of Section 18 of the Exchange Act. It will only be incorporated by reference in other filings if expressly set forth. The filing also lists the Cover Page Interactive Data File as Exhibit 104.
Greg Dougherty, a director of MaxLinear, Inc. (MXL), amended his Form 4 to report an award of 15,741 restricted stock units (RSUs) granted with a transaction date of
MaxLinear, Inc. (MXL) filed an amended Form 4 disclosing a grant of 15,741 restricted stock units (RSUs) to director Albert J. Moyer. The RSUs were granted on
MaxLinear, Inc. director Carolyn Beaver amended her Form 4 to report the grant of 15,741 restricted stock units (RSUs) on
Thomas E. Pardun, a director of MaxLinear, Inc. (MXL), amended a Form 4 to report an award of 15,741 restricted stock units (RSUs) granted on
The RSUs vest 100% on the earlier of
MaxLinear, Inc. director Daniel A. Artusi amended a Form 4 to report receipt of 15,741 restricted stock units (RSUs) granted on